XENE Q1 2020 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M

Gross Profit

$7M100.0% margin

Operating Income

-$8M-113.5% margin

Net Income

-$7M-105.7% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+112.6%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$237M

Total Liabilities

$49M

Stockholders' Equity

$188M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$0	—
Gross Profit	$7M	-$9M	+177.5%
Operating Income	-$8M	-$12M	+31.7%
Net Income	-$7M	-$11M	+34.0%